Pharma News from PharmiWeb.com

On the Road to the Cure: Innovation and Signature Treatments at Georgetown Lombardi

Wed, 11 Nov 2009 17:00:00 PST

On the Road to the Cure: Innovation and Signature Treatments at Georgetown Lombardi
How can counting cancer cells in the blood m...
Georgetown University Medical Center

Landmark Study in The Lancet Oncology Shows Capecitabine (Xeloda(R)) Combination Therapy Reduces Early Breast Cancer Recurrence

Wed, 11 Nov 2009 17:00:00 PST

Landmark Study in The Lancet Oncology Shows Capecitabine (Xeloda(R)) Combination Therapy Reduces Early Breast Cancer Recurrence
...
The Finnish Breast Cancer Group

GP support helps accelerate new drug development

Wed, 11 Nov 2009 17:00:00 PST

GP support helps accelerate new drug development
GP support helps accelerate new drug development But more patient awareness ne...
LCG Bioscience

PIKAMAB to Customize Cancer Antibody Therapies

Wed, 11 Nov 2009 17:00:00 PST

PIKAMAB to Customize Cancer Antibody Therapies
PIKAMAB, a stratified medicine biopharmaceutical company, announced today that it...
PIKAMAB

i3 Pharma Resourcing launches new resourcing services

Wed, 11 Nov 2009 17:00:00 PST

i3 Pharma Resourcing launches new resourcing services
i3 Pharma Resourcing, a leading global provider of quality clinical resea...
i3 Pharma Resourcing

NextPharma Technologies Receives Approval from the AFMPS at its Sterile Product Development Center in Belgium

Wed, 11 Nov 2009 17:00:00 PST

NextPharma Technologies Receives Approval from the AFMPS at its Sterile Product Development Center in Belgium
Surrey, UK, 4th...
NextPharma

Deadline Extended to December 16 to Submit Nominations for Depression Awards Program

Wed, 11 Nov 2009 17:00:00 PST

Deadline Extended to December 16 to Submit Nominations for Depression Awards Program
NEW YORK, Nov 11, 2009 /PRNewswire-FirstCal...
Lilly

Watson Announces Presentation Time Change at Credit Suisse Healthcare Conference

Wed, 11 Nov 2009 17:00:00 PST

Watson Announces Presentation Time Change at Credit Suisse Healthcare Conference
MORRISTOWN, N.J., Nov. 10 /PRNewswire-FirstCall...
Watson

Analysis Underscores Financial Burden of Mental Illness on Criminal Justice and Health Care Systems

Wed, 11 Nov 2009 17:00:00 PST

Analysis Underscores Financial Burden of Mental Illness on Criminal Justice and Health Care Systems
Philadelphia, PA (November 1...
Johnson & Johnson

Hypoglycemia Education - A Vital Weapon in the Battle to Conquer Diabetes

Wed, 11 Nov 2009 17:00:00 PST

Hypoglycemia Education - A Vital Weapon in the Battle to Conquer Diabetes
Hypoglycemia Education - A Vital Weapon in the Battle ...
ESP Bioscience

Bend Memorial Clinic Pursues Recruitment in Lung Cancer Trial

Wed, 11 Nov 2009 17:00:00 PST

Bend Memorial Clinic Pursues Recruitment in Lung Cancer Trial
The Bend Memorial Clinic is recruiting patients for a Phase III lu...
Bend Memorial Clinic

Interim Management Statement

Tue, 10 Nov 2009 17:00:00 PST

Interim Management Statement
11 November 2009 - Ark Therapeutics Group plc ('Ark' or the 'Company') today pu...
Ark Therapeutics Group plc

Once-Daily INTUNIV™ (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide

Tue, 10 Nov 2009 17:00:00 PST

Once-Daily INTUNIV™ (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide
In clinical studies, INTUNIV, a...
Shire

Bristol-Myers Squibb and Alder Biopharmaceuticals Enter Global Agreement on Rheumatoid Arthritis Biologic

Tue, 10 Nov 2009 17:00:00 PST

Bristol-Myers Squibb and Alder Biopharmaceuticals Enter Global Agreement on Rheumatoid Arthritis Biologic
ALD518 is a Phase II H...
Bristol-Myers Squibb

Landmark study in The Lancet Oncology shows capecitabine (Xeloda®) combination therapy reduces early breast cancer recurrence

Tue, 10 Nov 2009 17:00:00 PST

Landmark study in The Lancet Oncology shows capecitabine (Xeloda®) combination therapy reduces early breast cancer recurrence
La...
Roche

Bristol-Myers Squibb to Present at Credit Suisse Healthcare Conference

Tue, 10 Nov 2009 17:00:00 PST

Bristol-Myers Squibb to Present at Credit Suisse Healthcare Conference
NEW YORK(BUSINESS WIRE)Bristol-Myers Squibb Company (NYSE...
Bristol-Myers Squibb

Neutrogena Launches Online Holiday Shopping Destination

Tue, 10 Nov 2009 17:00:00 PST

Neutrogena Launches Online Holiday Shopping Destination
Seasonal discounts on best-selling products are available at Holiday.Neu...
Johnson & Johnson

Teva Receives Final Approval For Generic

Tue, 10 Nov 2009 17:00:00 PST

Teva Receives Final Approval For Generic
Jerusalem, Israel, November 10, 2009 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TE...
Teva

Teva Receives Favorable Court Decision Regarding Generic Prevacid® Solutab

Tue, 10 Nov 2009 17:00:00 PST

Teva Receives Favorable Court Decision Regarding Generic Prevacid® Solutab
Jerusalem, Israel, November 10, 2009 - Teva Pharmaceu...
Teva

New Data Shows Kidney Disease Rising Due to Rampant Rates of Diabetes

Mon, 09 Nov 2009 17:00:00 PST

New Data Shows Kidney Disease Rising Due to Rampant Rates of Diabetes
New data confirms the rate of chronic kidney disease is in...
TMF Health Quality Institute

UKCPA APPOINTS INTERIM ASSOCIATION CHAIR

Mon, 09 Nov 2009 17:00:00 PST

UKCPA APPOINTS INTERIM ASSOCIATION CHAIR
The UKCPA is delighted to announce that Ms Helena Hodges will be acting Chair of UKCPA ...
UKCPA

Pfizer Announces Global Research Network

Mon, 09 Nov 2009 17:00:00 PST

Pfizer Announces Global Research Network
NEW YORK(BUSINESS WIRE)Pfizer Inc today announced its global research and development n...
Pfizer

Ismail Kola joins UCB as Executive Vice President, UCB & President of UCB New Medicines(TM)

Mon, 09 Nov 2009 17:00:00 PST

Ismail Kola joins UCB as Executive Vice President, UCB & President of UCB New Medicines(TM)
Brussels, Belgium, 10 November 2...
UCB

GSK signs agreement with the WHO to donate 50 million doses of pandemic H1N1 vaccine for distribution to developing countries

Mon, 09 Nov 2009 17:00:00 PST

GSK signs agreement with the WHO to donate 50 million doses of pandemic H1N1 vaccine for distribution to developing countries
Gl...
GlaxoSmithKline

Trinity Health Selects Seven Elsevier Clinical Decision Support Solutions for its Multiple Facilities In Seven States

Mon, 09 Nov 2009 17:00:00 PST

Trinity Health Selects Seven Elsevier Clinical Decision Support Solutions for its Multiple Facilities In Seven States
Trinity He...
Elsevier

Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million

Mon, 09 Nov 2009 17:00:00 PST

Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million...
Hard to Treat Diseases (HTDS)

Astellas Pharma Europe Announces Save the Children as a Winner of the Changing Tomorrow 2009 Awards

Mon, 09 Nov 2009 17:00:00 PST

Astellas Pharma Europe Announces Save the Children as a Winner of the Changing Tomorrow 2009 Awards
Astellas Pharma Europe Annou...
Astellas Pharma Europe Limited

Teva Files Amended Complaint Against Momenta/Sandoz to Include Infringement of Three COPAXONE®-Related Patents

Mon, 09 Nov 2009 17:00:00 PST

Teva Files Amended Complaint Against Momenta/Sandoz to Include Infringement of Three COPAXONE®-Related Patents
Teva Pharmaceutic...
Teva Pharmaceutical Industries Ltd.

New Medicare Benefit to Provide Chronic Kidney Disease Patients with Education on Treatment Options

Mon, 09 Nov 2009 17:00:00 PST

New Medicare Benefit to Provide Chronic Kidney Disease Patients with Education on Treatment Options
Baxter International Inc. (N...
Baxter International Inc.

NHS Scotland approves use of VELCADE ®? (bortezomib) in a wider range of patients and introduces Janssen-Cilag’s innovative patient access scheme.

Sun, 08 Nov 2009 17:00:00 PST

NHS Scotland approves use of VELCADE ®? (bortezomib) in a wider range of patients and introduces Janssen-Cilag’s innovative patient access sch...
Janssen-Cilag